Search Results 781-790 of 17194 for treatment resistant depression
"Further, the molecular mechanisms underlying insulin resistance in lipodystrophy and its amelioration by leptin therapy need to be elucidated. We are ...
The primary purpose of this study is to evaluate patient-reported health-related quality of life outcomes in subjects with Relapsed/Refractory Multiple Myeloma ...
This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers.
― Advanced treatments ... Researchers at Mayo Clinic are exploring its potential in treating conditions like epilepsy, dementia, depression, addiction, and ...
The purpose of this Phase 1a/1b study of SC-003 in patients with platinum-resistant/refractory ovarian cancer is to characterize the safety and tolerability of ...
... resistant to treatment. A Dose-Finding Study of Folotyn® (Pralatrexate ... refractory to standard therapy or for whom there is no standard therapy.
... Therapy for the Treatment ... Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic ...
Learn of Mayo Clinic's capabilities in nuclear medicine therapy, including PRRT with Lutathera, which doctors use to treat neuroendocrine tumors.
Diagnosis of major depression disorder, acute anxiety disorder or schizophrenia per medical record; Participating in other psychosocial intervention research ...
It is used in patients who have received complete or partial treatment with platinum-based cancer medicines. ... resistant to medical or surgical treatments that ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.